Cartesian Therapeutics, Inc removed from NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.26 USD | +15.02% | +14.88% | +36.64% |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
May. 22 | Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.64% | 437M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Cartesian Therapeutics, Inc.(NasdaqGM: RNAC) dropped from NASDAQ Biotechnology Index